Literature DB >> 1407014

Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.

S Sarre1, P Herregodts, D Deleu, A Devrieze, N De Klippel, G Ebinger, Y Michotte.   

Abstract

Microdialysis was used to study the biotransformation of L-DOPA in the striatum and substantia nigra of rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the substantia nigra. The animals were pretreated with carbidopa (50 mg/kg p.o.) for 5 days. They were anaesthetized, and microdialysis probes were implanted into the intact and denervated striatum and into the intact and lesioned substantia nigra. The biotransformation of L-DOPA (5 mg/kg i.p.) in these regions was investigated. These results were compared with those obtained after administration of a much higher dose of L-DOPA (100 mg/kg i.p.). Changes in extracellular L-DOPA, 3-O-methyldopa (3-OMD), dopamine, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were determined by HPLC with electrochemical detection. Although rats with a unilateral nigrostriatal lesion did not show rotational behaviour after 5 mg/kg L-DOPA, DA levels were increased significantly both in the intact and the denervated striatum and in the intact and the lesioned substantia nigra. This increase was most pronounced in the denervated striatum. At 100 mg/kg L-DOPA, the increases in extracellular dopamine in intact and denervated striatum were about twice as high as the increases observed at the lower dose. A similar increase was observed in the intact substantia nigra. However, in the lesioned substantia nigra there was a fourfold increase. L-DOPA, at both doses, was evenly distributed between the brain areas studied and the lesion had no effect on the uptake of the drug at the blood-brain barrier.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407014     DOI: 10.1007/bf00173540

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

Review 1.  Microdialysis--theory and application.

Authors:  H Benveniste; P C Hüttemeier
Journal:  Prog Neurobiol       Date:  1990       Impact factor: 11.685

2.  Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Siirtola
Journal:  Eur Neurol       Date:  1973       Impact factor: 1.710

3.  Autoradiographic localization of D1 and D2 dopamine receptors in the human brain.

Authors:  J De Keyser; A Claeys; J P De Backer; G Ebinger; F Roels; G Vauquelin
Journal:  Neurosci Lett       Date:  1988-08-31       Impact factor: 3.046

4.  Interdependence of the nigrostriatal dopaminergic systems on the two sides of the brain in the cat.

Authors:  A Nieoullon; A Cheramy; J Glowinski
Journal:  Science       Date:  1977-10-28       Impact factor: 47.728

5.  Analysis of zidovudine distribution to specific regions in rabbit brain using microdialysis.

Authors:  S L Wong; Y Wang; R J Sawchuk
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

6.  Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat.

Authors:  A Nieoullon; A Cheramy; J Glowinski
Journal:  Brain Res       Date:  1978-06-09       Impact factor: 3.252

Review 7.  Dendritic release of dopamine in the substantia nigra.

Authors:  A Cheramy; V Leviel; J Glowinski
Journal:  Nature       Date:  1981-02-12       Impact factor: 49.962

8.  Does contralateral circling involve action of drugs on hyposensitive striatal dopamine receptors in the hemisphere contralateral to denervation?

Authors:  B Costall; M E Kelly; R J Naylor
Journal:  Neuropharmacology       Date:  1983-03       Impact factor: 5.250

9.  D1 and D2 dopamine receptors in human substantia nigra: localization and the effect of aging.

Authors:  J De Keyser; J P De Backer; G Vauquelin; G Ebinger
Journal:  J Neurochem       Date:  1991-04       Impact factor: 5.372

10.  Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.

Authors:  A Dubois; M Savasta; O Curet; B Scatton
Journal:  Neuroscience       Date:  1986-09       Impact factor: 3.590

View more
  5 in total

1.  Effect of pergolide on endogenous and exogenous L-DOPA metabolism in the rat striatum: a microdialysis study.

Authors:  S Dethy; M A Laute; A Luxen; J Hildebrand; S Goldman
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 2.  Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain.

Authors:  S Navailles; M Lagière; A Contini; P De Deurwaerdère
Journal:  ACS Chem Neurosci       Date:  2013-04-15       Impact factor: 4.418

3.  Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-parkinsonian rat studied with microdialysis.

Authors:  S Sarre; N De Klippel; P Herregodts; G Ebinger; Y Michotte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

4.  Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Parkinsons Dis       Date:  2011-10-11

5.  Evaluation of blood-brain barrier transport and CNS drug metabolism in diseased and control brain after intravenous L-DOPA in a unilateral rat model of Parkinson's disease.

Authors:  Paulien Gm Ravenstijn; Henk-Jan Drenth; Michael J O'Neill; Meindert Danhof; Elizabeth Cm de Lange
Journal:  Fluids Barriers CNS       Date:  2012-02-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.